We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNVC icon
13826
CALL
NanoViricides
NNVC
$35.2M
$4.92K ﹤0.01%
4,200
-256,100
-98% -$346K
GFGDR
13827
DELISTED
The Growth for Good Acquisition Corporation Right
GFGDR
$4.92K ﹤0.01%
+27,334
New +$2.86K
RGLS
13828
DELISTED
Regulus Therapeutics
RGLS
$4.9K ﹤0.01%
5,786
-36,719
-86% -$48.6K
SCHO icon
13829
PUT
Schwab Short-Term US Treasury ETF
SCHO
$13B
$4.88K ﹤0.01%
200
-600
-75% -$14.5K
VINP icon
13830
CALL
Vinci Compass Investments Ltd
VINP
$626M
$4.88K ﹤0.01%
+600
New +$5.59K
THER
13831
CALL
DELISTED
THERATECHNOLOGIES INC COM
THER
$4.88K ﹤0.01%
+6,000
New +$4.88K
PRM icon
13832
PUT
Perimeter Solutions
PRM
$5.55B
$4.85K ﹤0.01%
600
REK icon
13833
ProShares Short Real Estate
REK
$11.7M
$4.84K ﹤0.01%
+242
New +$4.75K
PHUN icon
13834
PUT
Phunware
PHUN
$42.8M
$4.83K ﹤0.01%
136
-72
-35% -$3.33K
SCOR icon
13835
CALL
Comscore
SCOR
$94.1M
$4.8K ﹤0.01%
195
-55
-22% -$1.34K
LMBS icon
13836
PUT
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.4B
$4.79K ﹤0.01%
+100
New +$4.79K
HTLD icon
13837
CALL
Heartland Express
HTLD
$989M
$4.78K ﹤0.01%
300
-2,600
-90% -$42.3K
SPCK
13838
PUT
The SPAC and New Issue ETF
SPCK
$8.32M
$4.78K ﹤0.01%
200
-21,400
-99% -$514K
HEDJ icon
13839
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
$4.77K ﹤0.01%
116
-32,040
-100% -$1.26M
ALTG icon
13840
CALL
Alta Equipment Group
ALTG
$237M
$4.75K ﹤0.01%
300
-200
-40% -$3.36K
RPT
13841
PUT
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$4.75K ﹤0.01%
500
+300
+150% +$3.02K
THCX
13842
PUT
DELISTED
AXS Cannabis ETF
THCX
$4.73K ﹤0.01%
+220
New +$5.52K
NFBK
13843
CALL
DELISTED
Northfield Bancorp
NFBK
$4.71K ﹤0.01%
400
+300
+300% +$4.29K
NFBK
13844
PUT
DELISTED
Northfield Bancorp
NFBK
$4.71K ﹤0.01%
+400
New +$5.72K
METV icon
13845
PUT
Roundhill Ball Metaverse ETF
METV
$213M
$4.69K ﹤0.01%
500
-200
-29% -$1.71K
BTMDW
13846
DELISTED
Biote Corp. Warrant
BTMDW
$4.66K ﹤0.01%
+11,100
New +$4.03K
SIEN
13847
PUT
DELISTED
Sientra, Inc.
SIEN
$4.62K ﹤0.01%
3,000
+2,840
+1,775% +$5.04K
DYN icon
13848
PUT
Dyne Therapeutics
DYN
$4.8B
$4.61K ﹤0.01%
400
-3,800
-90% -$49.4K
TBLAW
13849
DELISTED
Taboola.com Ltd Warrant
TBLAW
$4.6K ﹤0.01%
11,217
+357
+3% +$222
ANY icon
13850
Sphere 3D
ANY
$18.1M
$4.6K ﹤0.01%
186
-2,739
-94% -$71.8K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.